Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, Ro-associated Y4 pseudogene 24 (RNY4P24)
- Target
- RNY4P24
- Molecular classification
- Other (non-coding RNA pseudogene), YRNA pseudogene
01
Overview
"RNA, Ro-associated Y4 pseudogene 24" (RNY4P24) is a non-coding RNA classified as a pseudogene member of the YRNA family. Unlike its parent gene, RNY4, which has roles in RNA processing and has been linked to cancer biomarker research, RNY4P24 does not encode a functional RNA and is presumed transcriptionally inactive. Pseudogenes such as RNY4P24 typically arise from duplication or retrotransposition events and generally lack biological or therapeutic function. Current evidence indicates that only the parent gene RNY4 and its products, not its pseudogenes, are studied for functional roles or clinical utility[3][4][6].
- Other names
- RNY4P24RNA, Ro-associated Y4 pseudogene 24Y4 RNA pseudogene 24
02
Mechanism of action
Not applicable
03
Biological functions
No known specific biological function has been described for RNY4P24YRNA pseudogenes are generally considered transcriptionally inactive and do not have a functional role[4][6].
04
Disease associations
No established direct disease role for RNY4P24Some YRNA fragments from parent genes (such as RNY4) have been studied as biomarkers in cancer and other conditions, but there is no evidence linking the pseudogene RNY4P24 itself to disease processes[1][2][4].
05
Safety considerations
None known
06
Interacting drugs
None known
07
Biomarkers
The functional YRNA gene (RNY4) and its fragments, not the pseudogene RNY4P24, have been studied as circulating biomarkers in cancers such as anaplastic large cell lymphoma, non-small cell lung cancer, and chronic lymphocytic leukemia, often being enriched in exosomes of patients[1][2][4].There is no evidence RNY4P24 is itself used as a biomarker.
Beyond the preview
Go deeper on RNA, Ro-associated Y4 pseudogene 24 (RNY4P24).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, Ro-associated Y4 pseudogene 24 (RNY4P24).